IP Library › Granted Patent US 7,846,975
Granted Patent B2
US 7,846,975 · App. 11/815,339 · Granted Dec 7, 2010

Molecular transporters based on sugar and its analogues and processes for the preparation thereof

Assignees: Postech Foundation; Postech Academy-Industry Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,975
App. No.
11/815,339
Granted
Dec 7, 2010
Kind
B2
Abstract

The inventive molecular transporter compound shows significantly high permeability through a biological membrane such as a plasma membrane, nuclear membrane and blood-brain barrier, and accordingly, can be effectively used in delivering various biologically active molecules.

Claims (23)

1. A sugar alcohol of formula (1):

wherein,

R 1 and R 2 are each independently H, alkyl, arylalkyl, cycloalkyl, heteroalkyl, —(CH 2 ) m NHR′, —(CH2) l CO 2 R″, —COR′″, —SO 2 R″″ or a physiologically active molecule; R′, R″, R′″ and R″″ being each independently H, alkyl, arylalkyl, cycloalkyl, heteroalkyl or a physiologically active molecule; m being an integer in the range of 2 to 5; and l being an integer in the range of 1 to 5;

R 3 is

n being an integer in the range of 1 to 12.

2. The sugar alcohol of claim 1 , which is an alditol having the skeleton of sorbitol, mannitol, galactitol, or a salt thereof.

3. A sugar alcohol of formula (4):

wherein,

R is

n being an integer in the range of 1 to 12.

4. The sugar alcohol of claim 3 , which is an alditol having the skeleton of sorbitol, mannitol, galactitol, or a salt thereof.

5. A composition for delivering a biologically active molecule across a biological membrane into a cell, wherein the biologically active molecule is selected from the group consisting of a peptide, a nucleic acid, a therapeutic molecule, and a diagnostic agent, comprising the compound of formula (1) or formula (4):

wherein, R 1 , R 2 and R 3 are the same as defined in claim 1 , or

wherein, R 1 is the same as defined in claim 3 ,

and the biologically active agent.

6. The composition of claim 5 , wherein the biologically active molecule is an organic compound having a molecular weight ranging from 100 to 1500 g/mol.

7. The composition of claim 5 , wherein the biologically active molecule is a peptide and a nucleic acid.

8. The composition of claim 5 , wherein the compound of formula 1 forms a conjugate with the biologically active molecule through a covalent bond.

9. The composition of claim 5 , wherein the compound of formula 1 forms an ionic complex with the biologically active molecule through ionic bonds.

10. A method for delivering a biologically active molecule across a biological membrane into a cell, wherein the biologically active molecule is one selected from the group consisting of a peptide, a nucleic acid, a therapeutic molecule, and a diagnostic agent, which comprises the step of employing a compound selected from the group consisting of the compounds of formula (1) or (4) as a molecular transporter:

wherein, R 1 , R 2 and R 3 are the same as defined in claim 1 , or

Wherein, R 1 is the same as defined in claim 3 ,

for delivery with the biologically active molecule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2007
From: CHUNG, SUNG-KEE; MAITI, KAUSTABH KUMAR; LEE, WOO SIRL; JEON, OCK-YOUM; YU, SEOK-HO
To: POSTECH FOUNDATION; POSTECH ACADEMY-INDUSTRY FOUNDATION
Reel/Frame 019637/0037 →
Priority Claims (1)
KR 10-2005-0035410 · Apr 28, 2005 · national
Continuity (1)
Related Publication 20080249296A1 · Oct 9, 2008